JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4776
FT Vest US Equity Deep Buffer ETF November
DNOV
$405M
| $531K | ﹤0.01% |
10,873
+9,094
| +511% | +$435K |
2024 Q2
6 quarters
|
|
|
INVX
4777
Innovex International
INVX
$1.91B
| $531K | ﹤0.01% |
24,278
-5,730
| -19% | -$120K |
2013 Q2
50 quarters
|
|
|
NFBK
4778
DELISTED
Northfield Bancorp
NFBK
| $530K | ﹤0.01% |
46,405
-60,062
| -56% | -$665K |
2013 Q2
50 quarters
|
|
4779
Nordic American Tanker
NAT
$1.78B
| $530K | ﹤0.01% |
154,182
-11,141
| -7% | -$39.4K |
2015 Q1
43 quarters
|
|
|
OACC
4780
Oaktree Acquisition Corp III Life Sciences
OACC
$265M
| $530K | ﹤0.01% |
49,894
-24,923
| -33% | -$264K |
2025 Q2
2 quarters
|
|
|
VLOS
4781
Velos Acquisition I Corp
VLOS
$252M
| $530K | ﹤0.01% |
49,847
+15,215
| +44% | +$162K |
2025 Q2
2 quarters
|
|
4782
CALL
Joby Aviation
JOBY
$5.93B
| $529K | ﹤0.01% |
40,100
+39,900
| +19,950% | +$612K |
2025 Q3
1 quarter
|
|
4783
AnaptysBio
ANAB
$1.45B
| $529K | ﹤0.01% |
10,916
-3,936
| -27% | -$153K |
2017 Q1
35 quarters
|
|
|
SBXD
4784
DELISTED
SilverBox Corp IV
SBXD
| $529K | ﹤0.01% |
50,000
| – | – |
2025 Q2
2 quarters
|
|
4785
U-Haul Holding Co
UHAL
$12B
| $528K | ﹤0.01% |
10,465
+831
| +9% | +$44.2K |
2013 Q2
50 quarters
|
|
|
BLUWU
4786
Blue Water Acquisition Corp III Unit
BLUWU
$216M
| $528K | ﹤0.01% |
50,000
-100,000
| -67% | -$1.03M |
2025 Q2
2 quarters
|
|
|
POLE
4787
Andretti Acquisition Corp II
POLE
$148M
| $526K | ﹤0.01% |
+49,873
| New | +$526K |
2025 Q4
0 quarters
|
|
|
KMTS
4788
Kestra Medical Technologies
KMTS
$1.63B
| $525K | ﹤0.01% |
19,789
+5,364
| +37% | +$138K |
2025 Q2
2 quarters
|
|
|
NBP
4789
NovaBridge Biosciences American Depositary Shares
NBP
$156M
| $525K | ﹤0.01% |
131,830
-18,334
| -12% | -$81.1K |
2025 Q3
1 quarter
|
|
|
PVLA
4790
Palvella Therapeutics
PVLA
$1.91B
| $524K | ﹤0.01% |
5,006
+668
| +15% | +$57K |
2017 Q3
33 quarters
|
|
4791
Acacia Research
ACTG
$424M
| $524K | ﹤0.01% |
140,037
+37,006
| +36% | +$133K |
2015 Q4
40 quarters
|
|
|
TACHU
4792
Titan Acquisition Corp Units
TACHU
| $523K | ﹤0.01% |
50,000
| – | – |
2025 Q2
2 quarters
|
|
4793
CALL
Legend Biotech
LEGN
$3.61B
| $522K | ﹤0.01% |
+24,000
| New | +$687K |
2025 Q4
0 quarters
|
|
|
4794
PUT
Legend Biotech
LEGN
$3.61B
| $522K | ﹤0.01% |
+24,000
| New | +$687K |
2025 Q4
0 quarters
|
|
|
RDAGU
4795
Republic Digital Acquisition Co Unit
RDAGU
| $522K | ﹤0.01% |
50,000
| – | – |
2025 Q2
2 quarters
|
|
4796
FT Vest US Equity Moderate Buffer ETF August
GAUG
$420M
| $521K | ﹤0.01% |
+13,275
| New | +$516K |
2025 Q4
0 quarters
|
|
|
GPMT
4797
Granite Point Mortgage Trust
GPMT
$36.7M
| $520K | ﹤0.01% |
216,838
-6,062
| -3% | -$16.3K |
2017 Q4
32 quarters
|
|
|
JENA.U
4798
Jena Acquisition Corp II Units
JENA.U
$220M
| $520K | ﹤0.01% |
50,000
-48,500
| -49% | -$510K |
2025 Q2
2 quarters
|
|
|
RAC
4799
Rithm Acquisition Corp
RAC
$310M
| $520K | ﹤0.01% |
50,000
-65,000
| -57% | -$673K |
2025 Q2
2 quarters
|
|
4800
Schwab 1000 Index ETF
SCHK
$5.78B
| $519K | ﹤0.01% |
15,826
-1,091
| -6% | -$35.5K |
2022 Q3
13 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.